Receptos Pharmaceuticals Inc Acquires Apoptos Inc for Undisclosed Sum
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5b532f4b-a08b-4978-a83f-cbad6b4d3f21&Preview=1 -
Date
6/26/2009 -
Company Name
Apoptos Inc -
Mailing Address
10835 Road to the Cure San Diego, CA 92121 -
Company Description
Apoptos Inc. is focused on developing novel small molecule drug therapies that directly induce tumor cell apoptosis. Using founding technology licensed from Burnham Institute for Medical Research, Fred Hutchinson Cancer Research Center, and Torrey Pines Institute for Molecular Studies, Apoptos is pioneering its anticancer platforms in close collaborations with preeminent scientists in the fields of apoptosis and experimental cancer therapy. Evasion of apoptosis pathways is central to cancer cell survival and reactivation of these cell-death pathways offers attractive anticancer drug development opportunities. -
Website
http://www.apoptos.com -
Transaction Type
M&A -
Transaction Amount
Undisclosed -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Financial terms of the transaction were not disclosed.
